EPO showed potential for treatment of ischemic stroke in a Phase I clinical trial, but the beneficial effect of EPO administration in ischemic stroke was not realized in an expanded Phase II/III clinical trial (Ehrenreich et al., 2002; Ehrenreich et al., 2009). Here, EPO is linked to ischemic stroke.